Lifestyle precision medicine: the next generation in type 2 diabetes prevention?
Open/View files
Date
2017
Author(s)
Mutie, Pascal M.
Giordano, Giuseppe N.
Publisher
BioMed Central
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Mutie, Pascal M., Giuseppe N. Giordano, and Paul W. Franks. 2017. “Lifestyle precision medicine: the next generation in type 2 diabetes prevention?” BMC Medicine 15 (1): 171. doi:10.1186/s12916-017-0938-x. http://dx.doi.org/10.1186/s12916-017-0938-x.
Abstract
The driving force behind the current global type 2 diabetes epidemic is insulin resistance in overweight and obese individuals. Dietary factors, physical inactivity, and sedentary behaviors are the major modifiable risk factors for obesity. Nevertheless, many overweight/obese people do not develop diabetes and lifestyle interventions focused on weight loss and diabetes prevention are often ineffective. Traditionally, chronically elevated blood glucose concentrations have been the hallmark of diabetes; however, many individuals will either remain ‘prediabetic’ or regress to normoglycemia. Thus, there is a growing need for innovative strategies to tackle diabetes at scale. The emergence of biomarker technologies has allowed more targeted therapeutic strategies for diabetes prevention (precision medicine), though largely confined to pharmacotherapy. Unlike most drugs, lifestyle interventions often have systemic health-enhancing effects. Thus, the pursuance of lifestyle precision medicine in diabetes seems rational. Herein, we review the literature on lifestyle interventions and diabetes prevention, describing the biological systems that can be characterized at scale in human populations, linking them to lifestyle in diabetes, and consider some of the challenges impeding the clinical translation of lifestyle precision medicine. Electronic supplementary material The online version of this article (doi:10.1186/s12916-017-0938-x) contains supplementary material, which is available to authorized users.
Other Available Sources
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service
Collection